References from these publications were also reviewed for relevant data
Every one of these changes belongs to your doctor, guided by your HbA1c, your home glucose readings, and your history of hypoglycemia never to self-adjustment
Starting at too high of a dose or moving to the next higher dose too quickly can exacerbate GI symptoms such as indigestion, nausea, vomiting, diarrhea, or constipation to the point the patient may quit the therapy
Regulation of hepatic lipid metabolism: CRP influences hepatic lipid metabolism by promoting IR and enhancing the breakdown of adipose tissue, which releases free fatty acids into the liver
Learn more about Weight & Wellness Solutions Weight Loss Medication Update June 23, 2025 FDA permission for compounding of GLP-1 medications used for weight loss ends April 22